DAVITA INC. (DVA)
Data as of , from SEC Form 4 filings.
See up to 3 months of DVA. The 7-day demo opens the 1M and 3M ranges and puts DVA on your watchlist.
Start 7-day demoLatest DVA insider trades
About DAVITA INC. (DVA)
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
- DENVER, CO
- 78,000
- 1995
- XNYS
DVA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 182,980 | $36.51M |
| Grant or award | 8 | 2,224 | |
| Tax withholding / forfeiture | 1 | 7,501 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
DVA insider transactions (Form 4)
4085 Form 4 filings on record, the earliest from Nov 19, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David Paul Maughan - Officer | Tax withholding / forfeiture | Common Stock | 7,501 footnote F1 | $182.34 | $1.37M | |
| ||||||
| Jason M. Hollar - Director | Grant or award | Common Stock | 278 | $0.00 | - | |
 Barbara J. Desoer - Director | Grant or award | Common Stock | 278 | $0.00 | - | |
 Adam H. Schechter - Director | Grant or award | Common Stock | 278 | $0.00 | - | |
| Gregory J. Moore - Director | Grant or award | Common Stock | 278 | $0.00 | - | |
 Dennis W. Pullin - Director | Grant or award | Common Stock | 278 | $0.00 | - | |
 Wendy Lee Schoppert - Director | Grant or award | Common Stock | 278 | $0.00 | - | |
 Pamela M. Arway - Director | Grant or award | Common Stock | 278 | $0.00 | - | |
 Phyllis R. Yale - Director | Grant or award | Common Stock | 278 | $0.00 | - | |
| BERKSHIRE HATHAWAY INC - 10% Owner | Open-market sale | Common Stock | 182,980 | $199.55 | $36.51M | |
| Kathleen Alyce Waters - Officer | Open-market sale | Common Stock | 8,950 | $207.84 footnote F1 | $1.86M | |
| Kathleen Alyce Waters - Officer | Open-market sale | Common Stock | 6,455 | $209.17 footnote F3 | $1.35M | |
| ||||||
| Javier Rodriguez - Officer | Open-market sale | Common Stock | 39,407 | $209.28 footnote F2 | $8.25M | |
| Javier Rodriguez - Officer | Open-market sale | Common Stock | 30,000 | $209.50 footnote F1 | $6.29M | |
| ||||||
| Phyllis R. Yale - Director | Gift | Common Stock | 5,038 | $0.00 | - | |
| Dennis W. Pullin - Director | Grant or award | Common Stock | 250 | $0.00 | - | |
| Gregory J. Moore - Director | Grant or award | Common Stock | 250 | $0.00 | - | |
| Wendy Lee Schoppert - Director | Grant or award | Common Stock | 250 | $0.00 | - | |
| Pamela M. Arway - Director | Grant or award | Common Stock | 250 | $0.00 | - | |
| Phyllis R. Yale - Director | Grant or award | Common Stock | 250 | $0.00 | - | |
| Barbara J. Desoer - Director | Grant or award | Common Stock | 250 | $0.00 | - | |
| Adam H. Schechter - Director | Grant or award | Common Stock | 250 | $0.00 | - | |
| Jason M. Hollar - Director | Grant or award | Common Stock | 250 | $0.00 | - | |
| James O. Hearty - Officer | Option exercise | Common Stock | 5,784 | $110.63 | $640K | |
| James O. Hearty - Officer | Derivative | Common Stock | 3,231 footnote F1 | $198.10 | $640K | |
| James O. Hearty - Officer | Tax withholding / forfeiture | Common Stock | 1,117 footnote F2 | $198.10 | $221K | |
| James O. Hearty - Officer | Open-market sale | Common Stock | 15,000 | $193.98 footnote F3 | $2.91M | |
| James O. Hearty - Officer | Option exercise | Stock Appreciation Rights | 5,784 | $0.00 | - | |
| ||||||
| David Paul Maughan - Officer | Open-market sale | Common Stock | 13,456 | $199.25 footnote F2 | $2.68M | |
| David Paul Maughan - Officer | Open-market sale | Common Stock | 7,073 | $199.15 footnote F1 | $1.41M | |
| ||||||
| Joel Ackerman - Officer | Open-market sale | Common Stock | 51,471 | $192.10 footnote F1 | $9.89M | |
| ||||||
| James O. Hearty - Officer | Open-market sale | Common Stock | 2,184 | $174.87 | $382K | |
| BERKSHIRE HATHAWAY INC | Open-market sale | Common Stock | 1,220,376 | $149.84 | $182.86M | |
| Pamela M. Arway - Director | Grant or award | Common Stock | 332 | $0.00 | - | |
| Barbara J. Desoer - Director | Grant or award | Common Stock | 332 | $0.00 | - | |
| David Paul Maughan - Officer | Grant or award | Common Stock | 5,308 footnote F1 | $0.00 | - | |
| David Paul Maughan - Officer | Tax withholding / forfeiture | Common Stock | 5,339 footnote F3 | $150.72 | $805K | |
| David Paul Maughan - Officer | Tax withholding / forfeiture | Common Stock | 7,768 footnote F4 | $150.72 | $1.17M | |
| David Paul Maughan - Officer | Grant or award | Stock Appreciation Rights | 14,351 | $0.00 | - | |
| ||||||
| Phyllis R. Yale - Director | Grant or award | Common Stock | 332 | $0.00 | - | |
Item 2.02, 9.01
Item 1.01, 2.03, 5.07, 9.01
Item 2.02, 9.01
Recent DVA Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
Stock trades in DVA disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Julie JohnsonDemocrat, TX-32 | Sale |
DVA insider trading FAQ
What is the latest insider trade for DVA?
DAVITA INC. (DVA) had 10 insider filings in the last 90 days, with the most recent on 2026-09-24. The full record for DVA runs to 85 Form 4 filings, the earliest from 2024-11-19. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying DVA stock?
No insider purchases of DVA were filed in the last 90 days.
How many insiders are selling DVA stock?
1 insider sale of DVA was filed in the last 90 days, totaling $36.51M.
Where can I see DVA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects DVA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - David Paul Maughan view on EDGAR
- - Jason M. Hollar view on EDGAR
- - Barbara J. Desoer view on EDGAR
- - Adam H. Schechter view on EDGAR
- - Gregory J. Moore view on EDGAR
- - Dennis W. Pullin view on EDGAR
- - Wendy Lee Schoppert view on EDGAR
- - Pamela M. Arway view on EDGAR
- - Phyllis R. Yale view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where DVA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow DVA with a 7-day demo
- DVA on your watchlist
- Every DVA Form 4 filing on record
- Up to 3 months of DVA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
